Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Craig Bennison"'
Autor:
Sebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, Walter Bouwmeester, Roman Hájek, Marco Campioni, Craig Bennison, Weiwei Xu, Krystallia Pantiri, Marja Hensen, Evangelos Terpos, Stefan Knop
Publikováno v:
MDM Policy & Practice, Vol 4 (2019)
Background. We aimed to develop and validate a conceptual model of multiple myeloma (MM) that characterizes the attributes affecting disease progression and patient outcomes, and the relationships between them. Methods. Systematic and targeted litera
Externí odkaz:
https://doaj.org/article/c2ebbdcf76ee4e5b99f23be91891db11
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 15, Iss 3 (2014)
OBJECTIVE: To estimate the incremental cost‑effectiveness of hexaminolevulinate (Hexvix®) + Blue Light (H+BL) cystoscopy (compared to white light cystoscopy only) when used at initial transurethral resection of the bladder tumour (TURBT) for patie
Externí odkaz:
https://doaj.org/article/46d6797aefea40a79622e551209c3369
Autor:
Svenja Petersohn, Gilles Salles, Michael Wang, Jim Wu, Sally W. Wade, Claire L. Simons, Craig Bennison, Rubina Siddiqi, Weimin Peng, Ioana Kloos, Gab Castaigne, Georg Hess
Publikováno v:
Journal of Medical Economics. 25:730-740
The objective of this study is to estimate the cost-effectiveness of KTE-X19 versus standard of care (SoC) in the treatment of patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) post Bruton tyrosine kinase inhibitor (BTKi) treatment f
Autor:
Gian Luca Di Tanna, Michael Urbich, Heidi S. Wirtz, Barbara Potrata, Marieke Heisen, Craig Bennison, John Brazier, Gary Globe
Publikováno v:
Pharmacoeconomics
Background and Objectives New treatments and interventions are in development to address clinical needs in heart failure. To support decision making on reimbursement, cost-effectiveness analyses are frequently required. A systematic literature review
Autor:
Craig Bennison, Jisu Yoon, Georg-Alexander Pietsch, Marie-Pierre Nicolas, Cecile Koerber, Joao Carrasco
Publikováno v:
Advances in Therapy
Introduction Treatment of neovascular age-related macular degeneration (nAMD) has evolved with the advent of anti-vascular endothelial growth factor agents such that intravitreally administered aflibercept and ranibizumab (RBZ) have become the standa
Autor:
Xiaofeng Wang, Ruth A Duffy, Marjanne A Piena, Natalie Houwing, Heidi C. Waters, Carla W Kraan, Suresh Mallikaarjun, Craig Bennison
Publikováno v:
Pharmacoeconomics
Introduction Schizophrenia is a chronic mental disorder that worsens with each relapse. Long-acting injectable (LAI) antipsychotics may prevent the exacerbation of symptoms and occurrence of relapses through improved continuity of care. Different dos
Autor:
Nicholas Durno, Matthias Schwenkglenks, M. Barbier, Christian Knapp, Craig Bennison, Mathias Örtli
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care. 23(5)
Introduction Venetoclax in combination with rituximab (VEN + R) demonstrated prolonged overall survival (OS) and progression-free survival (PFS) for patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) in comparison to standard
Autor:
Daniel C. Malone, Michael Wang, Craig Bennison, Gregory A. Maglinte, Tim Inocencio, Claire L. Simons, Bijal Shah, Sally W. Wade
The objective of this study is to estimate the cost-effectiveness of KTE-X19 versus standard of care (SoC) in the treatment of relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients from a US healthcare perspective. A three-state partitioned-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e754079b103833472e9360cd96eaac
Autor:
Julia A. Haller, Ralph Schmidt, Pravin U. Dugel, Arshad M. Khanani, Benedicte Lescrauwaet, Craig Bennison, Alan L. Wagner
Publikováno v:
Journal of comparative effectiveness research. 9(4)
Aim: Evaluate the cost–effectiveness of ocriplasmin in symptomatic vitreomacular adhesion (VMA) with or without full-thickness macular hole ≤400 μm versus standard of care. Methods: A state-transition model simulated a cohort through disease hea
Autor:
Stefan Knop, Katja Weisel, Roman Hájek, Craig Bennison, Marco Campioni, K Pantiri, Evangelos Terpos, Meletios-Athanassios Dimopoulos, Walter Bouwmeester, Marja Hensen, Sebastian Gonzalez-McQuire, Weiwei Xu
Publikováno v:
MDM Policy & Practice, Vol 4 (2019)
MDM Policy & Practice
MDM Policy & Practice
Background. We aimed to develop and validate a conceptual model of multiple myeloma (MM) that characterizes the attributes affecting disease progression and patient outcomes, and the relationships between them. Methods. Systematic and targeted litera